Avita Medical Ltd (RCEL)

[Billr05]

Avita Therapeutics Access Event Set By Oppenheimer for Oct. 1

By Bloomberg Automation
(Bloomberg) -- Oppenheimer is hosting a corporate access company marketing event for Avita Therapeutics Inc. on Oct. 1.

==============================================
Title: Virtual: AVITA Therapeutics, Inc.
Summary: Oppenheimer will host a virtual company marketing with Avita Therapeutics Inc on October 1, 2020.
Host Contacts:
Corporate Access, [e-mail]
==============================================
Bloomberg data shows:
Oppenheimer Analyst Kevin Degeeter rates Avita Therapeutics outperform. Degeeter's price target of $45 implies another 86 percent return and is 25 percent above the consensus average of $36.02. Analyst price targets range from $5.91 to $60.

Avita Therapeutics has 7 buy recommendations, 0 holds and 0 sells
Market cap - $520.6 million

Short interest - 195,896 shares, representing 0.9 percent of the total float and 1.3 days average trading volume as of the latest data

The Relative Strength Index (RSI) indicates the company is neither overbought nor oversold

Shares of the company fell 4.3 percent in the last session to$24.25 and are down 46.7 percent this year
RCEL US Equity
Graphic Dashboard»
Related ticker:
RCEL US (Avita Therapeutics Inc)
To contact Bloomberg News for this story:
[phone] or [e-mail] story was produced by Bloomberg Automation.